Papillomavirus Infections
New Findings from University of Southern California in the Area of Papillomavirus Infections Published
Published in Vaccine Weekly, June 8th, 2011
2011 JUN 8 -- Data detailed in "Expression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regression" have been presented. "LIGHT, a ligand for the lymphotoxin-beta receptor, establishes lymphoid-like tissues inside tumor sites and recruits naive T cells into the tumor. However, whether these infiltrating T cells are specific for tumor antigens is not known," researchers in Los Angeles, United States report.
"We hypothesized that therapy with LIGHT can expand functional tumor-specific CD8(+) T cells that can be boosted using HPV16E6E7-Venezuelan equine encephalitis virus replicon particles...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2011-06-08)
More Articles from Vaccine Weekly
- Pediatric Vaccines
Meningitis Angels Founder Frankie Milley Speaks at CDC National Stakeholder Meeting Regarding Infant Vaccination - Managed Care
Research from V.N. Patel and Co-Researchers Yields New Findings on Managed Care - Vaccines
Clinical trial of malaria vaccine begins in Africa - Alzheimer Disease
Data from A.E. Roher et al Provide New Insights into Alzheimer Disease - Infectious Diseases
Data from Albert Einstein College of Medicine Advance Knowledge in Infectious Diseases - HIV/AIDS
Data on HIV/AIDS Detailed by Researchers at Imperial College - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
